Abstract: The invention relates to compounds of the formula I
in which the radicals R1, R2, R3 and A have the meaning mentioned in the description. The invention further relates to a process for the preparation of the compounds of the formula I by means of solid-phase synthesis, and use thereof as pharmaceuticals.
Abstract: The present invention relates to compounds of the formula I
A—B—D—E—F—G (I)
in which A, B, D, E, F and G have the meanings given in the patent claims, to their preparation and to their use as medicaments. The compounds of the invention are used as vitronectin receptor antagonists and as inhibitors of bone resorption.
Type:
Grant
Filed:
February 6, 2001
Date of Patent:
May 14, 2002
Assignees:
Hoechst Aktiengesellschaft, Genentech, Inc.
Inventors:
Volkmar Wehner, Hans Ulrich Stilz, Anuschirwan Peyman, Jochen Knolle, Jean-Marie Ruxer, Denis Carniato, Jean-Michel Lefrancois, Thomas Richard Gadek, Robert McDowell
Abstract: A DNA sequence is described for the gene therapy of diseases associated with the immune system. In its essential elements, the DNA sequence is composed of an activator sequence, a promoter module and a gene for the active substance. The activator sequence is activated in a cell-specific or virus-specific manner and this activation is regulated by the promoter module in a cell cycle-specific manner. The choice of activator sequence and active substance depends on the indication area. The DNA sequence is inserted into a viral or non-viral vector which is supplemented by a ligand having affinity for the target cell.
Abstract: Benzoylcyclohexanediones of the formula (I), process for their preparation and their use as herbicides and plant growth regulators are described.
In this formula (I), R11, R2, R3, R4, R5, R6 and R7 are various radicals, L is an alkylene chain, and Y and Z are a monoatomic bridge element.
Type:
Grant
Filed:
October 7, 1999
Date of Patent:
April 23, 2002
Assignee:
Hoechst Schering AgrEvo GmbH
Inventors:
Andreas Van Almsick, Lothar Willms, Thomas Auler, Hermann Bieringer, Christopher Rosinger
Abstract: Supported catalysts having a high sintering stability and comprising one or more noble metal cluster carbonyl compounds of the formula (1)
[HaMbNcLd(CO)x]n−An+
and their use for the dehydrogenation, hydrogenation and oxidation of organic compounds where
M and N
are, independently of one another, one or more metals
selected from the group consisting of Pt, Rh, Ir, Os, Ru, Ag,
Pd, Au, Ni, Fe, Co, Cu, Re, Mn;
L
is one or more neutral or anionic ligands which may be
identical or different;
(A)n+
is one or more cations which balance the charge of the
complex;
a
is an integer from 0 to 10, preferably from 0 to 6;
b
is an integer from 2 to 60;
c
is an integer from 0 to 30;
d
is an integer from 0 to 60;
x
is an integer from 1 to 120;
n
is the total charge of the complex which results from the
individual charges of the constituents and is greater than 0,
wher
Type:
Grant
Filed:
October 15, 1998
Date of Patent:
April 16, 2002
Assignee:
Hoechst Research & Technology
Inventors:
Alfred Hagemeyer, Harald Werner, Uwe Dingerdissen, Klaus Kühlein, John Meurig Thomas, Brian F. G. Johnson, D. S. Shephard, T. Maschmeyer
Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described.
Type:
Application
Filed:
April 13, 2001
Publication date:
April 11, 2002
Applicant:
Hoechst Marion Roussel Deutschland GmbH
Abstract: A method for providing a waterborne, inorganic barrier coating to a polyolefin substrate is described. The method involves applying a primer composition containing a vinyl polymer, wherein at least 75% of the polymer repeat units contain side groups having hydroxyl moieties, to the substrate. This primer coating facilitates the application and binding of the subsequently applied barrier coating composition to the substrate.
Type:
Grant
Filed:
May 15, 2001
Date of Patent:
April 9, 2002
Assignee:
Hoechst Trespaphan GmbH
Inventors:
Michael A. Hubbard, James A. McCaulley, Douglas R. Holcomb
Abstract: Process for preparation of hydrophilic or partially hydrophilic inorganic aerogels. The invention relates to a process for the preparation of hydrophilic or partially hydrophilic inorganic aerogels, which comprises pyrolyzing a hydrophobic inorganic aerogel in the presence of oxygen at temperatures in the range from 100 to 1000° C.
Abstract: Isocyanates of the formula (I)
in which X and Y are defined as in formula (I) of claim 1 can be prepared by reacting a compound of the formula (II) or its salts
in which X and Y are defined as in formula (I),
with 1 to 6 mol of phosgene per mole of compound of the formula (II), in the presence of 2 to 3.5 molar equivalents of a base per mole of compound of the formula (II) and in the presence of an aprotic organic solvent at a reaction temperature in the range from −30 to +60° C. to give the compound of the formula (I). The compounds (I) can be converted by reaction with nucleophiles to give addition products, such as carbamates, ureas and sulfonylureas and corresponding products, e.g. herbicidal sulfonylureas.
Abstract: A process for forming a pattern which comprises irradiating with light a film of a poly(arylenevinylene) polymer represented by the following formula (I)
—(Ar—CR1=CR2)n— (I)
wherein Ar is a substituted or unsubstituted divalent aromatic hydrocarbon group or a substituted or unsubstituted divalent heterocyclic ring group, and the aromatic hydrocarbon group and the heterocyclic ring group may be a fused ring, R1, R2 independently of each other, are H, CN, alkyl, alkoxy are substituted or unsubstituted aromatic hydrocarbon groups or substituted or unsubstituted aromatic heterocycles, which may both be fused rings, and n is an integer of 2 or more. It is preferred that either R1 or R2 is H and more preferred that both R1 and R2 are H.
Abstract: Glufosinate and the 2-methyl analog thereof can be prepared in a multi-step synthesis from methylphosphorus compounds (II) with unsaturated keto compounds (III) via adducts (IV), subsequent reaction under the conditions of a Strecker synthesis and finally hydrolysis of the aminonitrile (V):
Step 1:
Step 2:
Step 3: Hydrolysis of (V) to give glufosinate
Depending on process conditions and substrates, various compounds can be identified as adducts (IV).
Abstract: Wastewater from the aldolization reaction is purified by adjusting its pH to 0 to 6, followed by extraction with monohydric alcohols having at least 8 carbon atoms, hydrocarbons having at least 6 carbon atoms, and mixtures thereof. In some cases, adjustment of the pH causes the formation of an organic phase, which is separated from the remaining wastewater before extraction.
Type:
Grant
Filed:
May 1, 1996
Date of Patent:
March 19, 2002
Assignee:
Hoechst Aktiengesellschaft
Inventors:
Mariola Rötzheim, Wolfgang Greb, Wolfgang Zgorzelski, Carl Dieter Frohning, Klaus Denkmann, Heinz Kalbfell
Abstract: Use of xanthine derivatives for reducing the pathological hyperreactivity of eosinophilic granulocytes, novel xanthine compounds and process for their preparation.
Type:
Application
Filed:
February 8, 2001
Publication date:
January 24, 2002
Applicant:
Hoechst Aktiengesellschaft
Inventors:
Ulrich Gebert, Hiristo Anagnostopulos, Claus Kroegel, Alexander Kapp
Abstract: Novel spiro[cyclopent[b]indole-piperidines], intermediates and processes for the preparation thereof, and methods of relieving memory dysfunction and treating depression utilizing the spiro[cyclopent[b]indole-piperidines] and intermediates, or compositions thereof are disclosed.
Abstract: A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.
Type:
Grant
Filed:
July 20, 1999
Date of Patent:
January 8, 2002
Assignee:
Hoechst Aktiengesellschaft
Inventors:
Martin Schönharting, Stefan Müllner, Peter Zabel
Abstract: A coupled enzyme reaction of a transaminase with GOT activity and of a transaminase with L-phosphinothricin transaminase activity produces phosphinothricin in virtually quantitative yield and virtually without any contamination whatever by a natural amino acid when the amino donor glutamate is employed in catalytic amounts and the amino donor aspartate is employed in approximately equimolar amounts relative to 4-(hydroxymethylphosphinyl)-2-oxobutyric acid.
Type:
Grant
Filed:
March 22, 1995
Date of Patent:
January 1, 2002
Assignee:
Hoechst Aktiengesellschaft
Inventors:
Klaus Bartsch, Gerd Fülling, Arno Schulz